acitretin has been researched along with Acrodermatitis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutz, JP; Khosravi-Hafshejani, T; Zhou, Y | 1 |
| Dalle, S; Debarbieux, S; Garnier, L; Jullien, D; Saunier, J; Thomas, L | 1 |
| Li, S; Qi, Y; Qiu, L; Xiao, T; Zheng, S | 1 |
| Alomar, A; Barco, D; Puig, L; Vilarrasa, E | 1 |
| Silpa-archa, N; Wongpraparut, C | 1 |
| Lipsker, D; Lutz, V | 1 |
| Kirby, B; Tobin, AM | 1 |
| Argenziano, G; Cicale, L; Farro, P; Ferrara, G; Fulgione, E; Petrillo, G; Ruocco, E; Zalaudek, I; Zanchini, R | 1 |
| Nikkels, AF; Piérard, GE | 1 |
| Armingaud, P; Cambie, MP; Esteve, E; Huet, C; Kalis, B; Maquaire, J; Penouil, MH; Serpier, H | 1 |
| Raymakers, RA; Steijlen, PM; van der Kerkhof, PC | 1 |
| Kuijpers, AL; van de Kerkhof, PC; van Dooren-Greebe, RJ | 1 |
| Lambiris, AG; Newman, PL | 1 |
| Chang, A; Happle, R; van de Kerkhof, PC; van Dooren-Greebe, RJ | 1 |
2 review(s) available for acitretin and Acrodermatitis
| Article | Year |
|---|---|
Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
Topics: Acitretin; Acrodermatitis; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Humans; Infliximab; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Keratolytic Agents; Male; Middle Aged; Retreatment; Tumor Necrosis Factor Inhibitors; Ustekinumab | 2015 |
Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
Topics: Acitretin; Acrodermatitis; Adalimumab; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Clobetasol; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Methotrexate; Mycophenolic Acid; Nails; Paronychia; Psoriasis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor Inhibitors | 2010 |
12 other study(ies) available for acitretin and Acrodermatitis
| Article | Year |
|---|---|
Acrodermatitis Continua of Hallopeau with Psoriatic Arthritis.
Topics: Acitretin; Acrodermatitis; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Humans; Interleukin-17; Keratolytic Agents; Male; Middle Aged; Treatment Outcome; Withholding Treatment | 2019 |
Acrodermatitis Continua of Hallopeau with Granuloma-like Vegetation, Osteolysis and IL36RN Mutation.
Topics: Acitretin; Acrodermatitis; Female; Granuloma; Hand Dermatoses; Humans; Interleukins; Keratolytic Agents; Middle Aged; Mutation; Osteolysis | 2017 |
A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
Topics: Acitretin; Acrodermatitis; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Administration Schedule; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Keratolytic Agents; Receptors, Tumor Necrosis Factor; Treatment Outcome | 2011 |
Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.
Topics: Acitretin; Acrodermatitis; Antirheumatic Agents; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hypertriglyceridemia; Injections, Subcutaneous; Interleukin 1 Receptor Antagonist Protein; Keratolytic Agents; Middle Aged; Psoriasis; Receptors, Interleukin-1; Recombinant Proteins; Recurrence; Triglycerides; Tumor Necrosis Factor-alpha | 2012 |
Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.
Topics: Acitretin; Acrodermatitis; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Female; Hand; Humans; Keratolytic Agents; Middle Aged; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
Unusual association between acrokeratosis verruciformis of Hopf and multiple keratoacanthomas. Successful therapy with acitretin.
Topics: Acitretin; Acrodermatitis; Darier Disease; Humans; Keratoacanthoma; Keratolytic Agents; Leg; Male; Middle Aged; Rare Diseases; Treatment Outcome | 2004 |
Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
Topics: Acitretin; Acrodermatitis; Aged; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Keratolytic Agents; Psoriasis; Receptors, Tumor Necrosis Factor | 2006 |
[Bazex paraneoplastic acrokeratosis. Treatment with acitretin].
Topics: Acitretin; Acrodermatitis; Aged; Head and Neck Neoplasms; Humans; Keratosis; Lymphatic Metastasis; Male; Paraneoplastic Syndromes; Treatment Outcome | 1995 |
Acrodermatitis continua of Hallopeau in a patient with myelodysplastic syndrome.
Topics: Acitretin; Acrodermatitis; Acute Disease; Cell Transformation, Neoplastic; Contraindications; Humans; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Psoriasis | 1996 |
Acrodermatitis continua of Hallopeau: response to combined treatment with acitretin and calcipotriol ointment.
Topics: Acitretin; Acrodermatitis; Aged; Calcitriol; Dermatologic Agents; Drug Synergism; Drug Therapy, Combination; Female; Humans; Neutrophils; Ointments | 1996 |
Marginal papular acrokeratodermas: no racial limitations for a clinical spectrum that responds to acitretin.
Topics: Acitretin; Acrodermatitis; Adult; Female; Hearing Loss, Sensorineural; Humans; Keratolytic Agents; Keratosis | 2001 |
Acitretin monotherapy in acrodermatitis continua Hallopeau.
Topics: Acitretin; Acrodermatitis; Aged; Cell Movement; Fingers; Humans; Male; Neutrophils; Tretinoin | 1989 |